First- and third-generation epidermal growth factor receptor inhibitors mediate distinct phosphoprotein signalling networks: implications for adverse dermatological reactions.

Saved in:
Bibliographic Details
Title: First- and third-generation epidermal growth factor receptor inhibitors mediate distinct phosphoprotein signalling networks: implications for adverse dermatological reactions.
Authors: Vasavda C; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA., Ho BK; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA., Zhang DY; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA., Williams KA; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA., Kaffenberger BH; Division of Dermatology, Department of Internal Medicine, Ohio State University Wexner Medical Center, Columbus, OH, 43210, USA., Kwatra SG; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA., Kwatra MM; Department of Anesthesiology, Duke University School of Medicine, Durham, NC, 27701, USA.
Source: The British journal of dermatology [Br J Dermatol] 2020 Dec; Vol. 183 (6), pp. 1105-1107. Date of Electronic Publication: 2020 Jul 27.
Publication Type: Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1365-2133
DOI:10.1111/bjd.19263